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ABSTRACT		
	 In	recent	years,	the	obesity	epidemic	has	continued	to	grow	and	has	emerged	as	a	huge	
public	health	issue	over	the	last	decade.	Obesity	has	been	found	to	be	associated	with	a	
multitude	of	health	problems	including	cardiovascular	disease,	metabolic	syndrome,	arthritis	
and	overall	morbidity.	Additionally,	obesity	has	been	linked	to	a	decreased	antibody	immune	
response	to	influenza	vaccination.	Exercise	is	commonly	understood	to	have	health	benefit,	
both	in	mental	and	physical	health,	but	the	association	between	exercise	and	immune	response	
is	an	area	of	limited	research.		The	present	study	aimed	to	investigate	whether	exercise	in	both	
healthy	weight	and	overweight	individuals	would	enhance	the	antibody	immune	response	
following	influenza	vaccination.	Pre-	and	post-	vaccination	serum	samples	from	the	2013-2014	
study	year	were	used	to	determine	vaccine	antibody	titer	response	using	haemagglutination	
inhibition	assays.		Exercise	data	for	the	subjects	was	collected	from	a	self-reported	
questionnaire	administered	upon	pre-vaccination	blood	draw.	There	were	no	significant	
differences	between	pre-	and	post-vaccination	antibody	titers	between	non-exercisers	and	
exercisers	nor	was	there	one	between	the	four	body	weight-exercise	subgroups.	As	such	there	
was	also	no	significant	difference	between	antibody	titer	fold	change	between	subgroups.	
Although	the	data	was	restricted	by	limited	sample	size	and	possible	subgroup	
misclassifications	and	no	significant	differences	were	found,	there	were	trends	that	may	
suggest	that	exercise	plays	a	role	in	mediating	the	antibody	immune	response	in	healthy	weight	
and	overweight	individuals.		
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I.	Introduction	
a.	Obesity		
	 Obesity	has	become	an	epidemic	among	both	adults	and	children	in	the	United	States	in	
recent	years.	In	fact,	the	most	recent	data	shows	over	one-third	of	adults	and	16%	of	children	
are	classified	as	being	obese7.	Obesity	has	numerous	implications	on	human	health,	including	
both	the	psychological	and	physiological	states.		It	is	well	established	that	obesity	significantly	
increases	the	risk	for	a	multitude	of	chronic	illnesses	such	as	diabetes,	cardiovascular	disease,	
arthritis,	cancer,	and	overall	morbidity6.	A	link	between	excess	body	weight	in	obese	individuals	
and	impaired	immune	response	has	also	been	found.	This	decrease	in	immune	response	has	
been	investigated	in	bacterial	and	viral	infections,	and	proven	to	be	impaired	in	both.		
b.	Influenza		
	 Influenza	virus	is	an	annual	epidemic	that	causes	serious	respiratory	infection	in	3-5	
million	people	each	year4.	Of	these	cases,	over	an	estimated	250,000	result	in	death.	As	studies	
have	shown	that	obese	individuals	have	a	decreased	immune	response	to	infection,	this	finding	
is	also	consistent	with	decreased	influenza	immunity	in	obese	individuals.		Specifically,	an	
association	between	obesity	and	decreased	antibody	response	to	the	influenza	vaccination	has	
been	found9.	Influenza	vaccination	has	proven	to	serve	as	an	effective	tool	in	influenza	infection	
prevention.	The	vaccine	introduces	an	inactive	form	of	the	virus	that	allows	the	body	to	
develop	antibodies	against	the	particular	virus	strain.		The	production	of	these	antibodies	
produces	a	memory	response	specific	to	the	viral	strain.		In	the	case	that	an	individual	is	later	
exposed	to	the	live	virus,	the	body	elicits	this	antibody	memory	response	and	the	body	is	more	
effective	in	fighting	the	virus.	The	most	common	assessment	of	influenza	antibody	response	is	
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measurement	of	the	haemagglutination	inhibition	(HAI)	titer3.	HAI’s	determine	the	circulating	
level	of	influenza-specific	antibodies	that	can	inhibit	the	ability	of	the	virus	to	bind	to	lung	
epithelial	cells.		
c.	Exercise		
	 It	is	widely-accepted	that	exercise	has	a	variety	of	systemic	affects	on	the	body,	
including	reduced	risk	of	cardiovascular	disease,	increased	muscle	and	bone	strength,	and	
increased	mental	health6.	Prior	studies	also	show	that	exercise	has	positive	effects	on	the	
immune	response.	Furthermore,	increased	antibody	response	following	influenza	vaccination	
has	been	found	as	well.		Although	most	current	published	studies	on	this	topic	focus	on	older	
adults	rather	than	the	general	population	as	a	whole,	the	results	support	exercise	as	a	mediator	
of	immune	response.		Kohut	et.	al	found	that	in	older	adults	with	an	age-declined	influenza	
vaccine	response,	exercisers	experienced	a	greater	fold	increase	in	antibody	titer	in	response	to	
vaccination	as	compared	to	non-exercising	older	adults5.	A	similar	study	of	an	elderly	
population	found	significant	results	of	increased	immune	vaccination	response	following	a	10-
week	cardiovascular	exercise	intervention12.		
d.	Study	Aim	
	 In	order	to	better	understand	the	effectiveness	of	exercise	as	a	mediator	of	antibody	
response	to	influenza	vaccination,	we	used	HAI	titers	as	a	means	to	measure	antibody	
concentration.		We	were	interested	in	investigating	whether	exercise	can	enhance	influenza	
vaccine	immune	response	and	potentially	outweigh	the	impaired	immunity	that	has	been	found	
as	result	of	obesity.	To	best	determine	this,	serum	samples	from	Dr.	Melinda	Beck’s	2013-2014	
study	year	were	used	to	collect	antibody	responses	and	these	antibody	titers	were	then	
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compared	between	4	sample	subgroups:	healthy	weight	exercisers,	obese	exercisers,	healthy	
weight	non-exercisers,	and	obese	non-exercisers.	We	hypothesized	that	exercise	in	both	
healthy	weight	and	obese	individuals	would	produce	a	greater	influenza	antibody	response	to	
vaccination	compared	to	non-exercisers.	The	circulating	virus	strain	during	the	study	year	from	
which	serum	samples	were	used	included	the	2009	influenza	A	(H1N1)	and	corresponding	
vaccine	produced	by	the	A/California/7/2009	(H1N1)pdm09-like	virus.			
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II.	Methods	
a.	Study	Population		
	 This	study	is	part	of	a	larger,	ongoing	clinical	study	within	Dr.	Melinda	Beck’s	clinical	
biochemistry	research	lab	at	UNC	Gilling’s	School	of	Global	Public	Health.	Participants	are	
annually	recruited	through	the	University	of	North	Carolina’s	Family	Medicine	Center	located	in	
Chapel	Hill,	North	Carolina.	The	subjects	for	this	particular	study	included	587	subjects	18.6-
83.5	years	old	from	the	2013-2014	study	year	(Table	1).	In	mid-September	of	2013,	background	
demographics	such	as	height,	weight,	sex,	race,	and	calculated	body	mass	index	(BMI)	as	well	as	
a	self-reported	exercise	questionnaire	was	collected	upon	subject	enrollment.		
Variable		 Sample	Population		 Total	Population	
Sex—no.	(%)	 	 	
	 Male		 9	(60.0)	 209	(35.6)	
	 Female		 6	(40.0)	 378	(64.4)	
Age—year		 	 	
	 Mean	 49.0	±	18.1	 54.3	±	15.2	
BMI—kg/m3	 	 	
	 Mean	Overall	 24.3	±	3.2	 30.6	±	8.0	
	 Mean	in	Healthy	Weight	 21.5	±	2.5	 22.3	±	2.10	
	 Mean	in	Overweight	 26.7	±	1.0	 33.4	±	7.18	
Race—No.	(%)	 	 	
	 Caucasian	 12	(80.0)	 386	(62.7)	
	 African	American	 1	(6.7)	 181	(30.8)	
	 Asian	 1	(6.7)	 20	(3.4)	
	 Hispanic	 1	(6.7)	 13	(2.1)	
	 Mixed	Race	 0	(0.0)	 4	(0.68)	
	 Southeast	Asian	 0	(0.0)	 1	(0.17)	
Exercise	Level—No.	(%)	 	 	
	 Non-Exerciser	 7	(46.7)	 --	
	 Exerciser	 8	(53.3)	 --	
Weight	Status—No.	(%)	 	 	
	 Healthy	Weight	 7	(46.7)	 151	(25.7)	
	 Overweight	 8	(53.3)	 436	(74.3)	
Table	1.	Demographic	characteristics	of	2013-2014	study	subjects.		
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Variable		 Exercisers		 Non-Exercisers	
Sex—no.	(%)	 	 	
	 Male		 5	(62.5)	 4	(57.1)	
	 Female		 3	(37.5)	 3	(42.9)	
Age—year		 	 	
	 Mean	 43.6	±	17.6	 55.2	±	17.7	
BMI—kg/m3	 	 	
	 Mean	Overall	 23.6	±	3.4	 25.1	±	3.1	
	 Mean	in	Healthy	Weight	 20.9	±	2.7	 22.2	±	2.5	
	 Mean	in	Overweight	 26.3	±	1.1	 27.2	±	0.8	
Race—No.	(%)	 	 	
	 Caucasian	 7	(87.5)	 5	(71.4)	
	 African	American	 0	(0.0)	 1	(30.8)	
	 Asian	 0	(0.0)	 1	(14.3)	
	 Hispanic	 1	(12.5)	 0	(0.0)	
Weight	Status—No.	(%)	 	 	
	 Healthy	Weight	 4	(50.0)	 3	(42.9)	
	 Overweight	 4	(50.0)	 4	(57.1)	
	
Out	of	the	total	587	subject	study	population,	15	subjects	were	chosen	to	make	up	the	sample	
population	for	this	specific	study	(Table	1)	(Table	2).	The	subjects	were	placed	into	the	following	
subsets	based	on	their	classifications	for	weight	status	and	exercise	level:	healthy	weight	non-
exercisers,	overweight	non-exercisers,	healthy	weight	exercisers,	and	overweight	exercisers.		
BMI	was	used	to	define	body	weight	status.	A	BMI	less	than	25	kg/m3	classified	individuals	as	
healthy	weight,	while	a	BMI	in	the	25-29.99	kg/m3	range	was	overweight.		
	
	
	
Table	2.	Demographic	characteristics	of	exercisers	and	non-exercisers	of	the	sample	population.		
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b.	Determination	of	Exercise	Activity	Level		
Exercise	level	was	determined	through	a	self-reported	questionnaire	that	ranked	exercise	
frequency	and	type	from	on	a	scale	from	1-7.		The	Rapid	Assessment	of	Physical	Activity	(RAPA)	
questionnaire	and	was	used	(Fig.	2).	The	University	of	Washington	Promotion	Research	Center	
provided	examples	of	activity	intensity	levels	defined	as	light,	moderate,	and	vigorous	(Fig.	1).11	
This	questionnaire	is	approved	as	a	valid	measure	for	physical	activity	status.	According	to	the	
guidelines	set	forth	by	the	University	of	Washington	Health	Promotion	Research	Center,	those	
who	answered	1	and/or	2	were	classified	as	non-exercisers	while	6	and/or	7	were	classified	as	
an	exerciser.		
	
	
	
	
	
	
	
	
	
	
	
	
Figure	1.	Examples	of	physical	activity	intensity	levels	defined	by	the	University	
of	Washington	Promotion	Research	Center	for	the	Rapid	Assessment	of	
Physical	Activity	(RAPA)	questionnaire.	
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c.	Serum	Collection	
Prior	to	influenza	vaccination,	baseline	blood	samples	were	also	collected	from	subjects.		
Subjects	then	received	the	2013-2014	seasonal	trivalent	influenza	vaccine	which	included	the	
A/California/7/2009	(H1N1)pdm09-like	virus,	the	A(H3N2)	virus	antigenically	like	the	cell-
propagated	prototype	virus	A/Victoria/361/2011,	and	B/Massachusetts/2/2012-like	virus.		At	
follow	up	period	30	days	after	vaccination,	a	second	blood	sample	was	collected	from	subjects.	
Figure	2.	Rapid	Assessment	of	Physical	Activity	(RAPA)	questionnaire	
developed	by	University	of	Washington	Promotion	Research	Center	used	to	
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The	blood	was	collected	into	a	non-heparinized	tube	and	allowed	to	clot.	The	serum	was	then	
removed	and	stored	at	-80	°C	until	use.		
	
d.	Haemagglutination	inhibition	assay	(HAI)	
The	prevalent	virus	that	circulated	the	United	States	for	the	2013-2014	influenza	season	was	
the	2009	influenza	A	(H1N1),	influenza	A	(H3N2),	and	influenza	B.	Haemagglutination	inhibition	
assays	were	run	to	determine	the	antibody	titer	present	in	the	serum	samples	specifically	for	
the	2009	influenza	A	(H1N1)	virus.		The	serum	samples	were	treated	with	prepared	Receptor	
Destroying	Enzyme	(RDE)	to	a	final	dilution	of	1:10.		This	was	preformed	by	first	adding	90	µL	of	
RDE	to	30	µL	serum,	the	samples	were	incubated	at	37	°C	for	18	hours	then	heated	at	56	°C	for	
1	hour	and	allowed	to	cool	to	room	temperature.		A	total	of	180	µL	of	0.85%	physiological	
saline	was	added	to	each	sample.	Samples	were	then	placed	in	the	freezer	for	a	minimum	of	4	
hours		until	use.	Prior	to	each	HAI,	a	sample	of	2009	influenza	A	H1N1	virus	was	diluted	to	
8HAU/50µL	using	sterile	PBS.	To	ensure	the	virus	was	properly	diluted	to	this	ratio,	the	diluted	
virus	was	tested	to	determine	the	haemagglutination	unit	titer	using	fresh	turkey	red	blood	
cells	at	0.5%.	Following	the	HAU	titer	test,	an	HAI	was	performed	using	the	0.5%	turkey	RBC,	
diluted	1:10	serum	samples,	and	8HAU/50µL	prepared	virus	in	a	96	well	plate.		Serial	dilutions	
were	performed	followed	by	a	20-30-minute	incubation	period.	The	HAI	titer	was	determined	
as	the	last	serum	dilution	which	prevented	red	blood	cell	agglutination.		
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e.	Data	Analysis		
	 The	HAI	titer	was	recorded	for	each	individual.	In	addition	to	pre	and	post	vaccination	
HAI	titer,	the	fold	change	between	the	pre	and	post	time	point	was	determined	for	each	subject	
by	dividing	the	post-vaccination	titer	by	the	pre-vaccination	titer.	Data	was	analyzed	using	
GraphPad	Prism	6.0.	An	unpaired	t-test	was	used	to	analyze	the	statistically	significant	
difference	of	pre	and	post-vaccination	titers	between	the	non-exercisers	and	exercisers.	The	
four	subgroups’	pre-	and	post-vaccination	titer	values	were	then	compared	using	multiple	t	
tests	and	statistical	significance	was	determined	using	the	Holm-Sidak	method.		Titer	fold	
change	comparisons	between	the	four	subgroups	were	performed	and	statistical	significance	
was	determined	using	a	one-way	ANOVA.		
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III.	Results		
a.	Demographics	of	the	Study	Population	
For	this	study,	15	subjects	were	chosen	from	the	larger	2013-2014	study.	In	order	to	
investigate	a	possible	association	of	exercise	influencing	the	influenza	vaccine	antibody	
response,	subjects	were	split	into	4	subgroups:	healthy	weight	non-exercisers,	overweight	non-
exercisers,	healthy	weight	exercisers,	and	overweight	exercisers.		Subjects	were	chosen	to	best	
represent	the	total	population	while	also	controlling	for	potential	confounding	factors.	In	terms	
of	demographic	characteristics,	the	sample	population	was	a	fair	representation	of	the	total	
2013-2014	study	population	(Table	1).		Age	was	the	closest	match,	with	the	samples	average	
age	falling	within	5.3	years	of	the	total	population’s.		The	mean	overall	BMI	in	the	sample	was	
6.3	kg/m3	lower	than	that	of	the	total	population,	which	was	expected	as	the	sample	
population	was	selected	purposefully	to	have	equal	healthy	weight	and	overweight	subjects	
while	the	total	population	was	based	on	volunteer	subject	enrollment	and	not	controlled.	
Caucasians	represented	the	majority,	comprising	80%	in	the	sample	population	versus	62.7%	in	
the	total	population.		African	American	(6.7%),	Asian	(6.7%),	and	Hispanic	(6.7%)	were	
additional	races	included	in	the	sample	population.	On	the	other	hand,	sex	was	the	least	
representative	of	the	total	population	as	females	comprised	the	majority	of	the	total	
population	(64.4%)	but	only	made	up	40%	of	the	sample	subject	population.		
	 In	the	sample	population,	an	age	difference	of	11.6	years	was	found	between	non-
exercisers	and	exercisers.	Equal	amounts	of	females	were	found	in	both	groups,	with	one	more	
male	found	in	exercisers.	Caucasian	subjects	made	up	5	of	the	7	non-exercisers	with	two	
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subjects	identified	as	African	American	and	Asian.	In	the	exercisers,	7	of	the	8	subjects	
identified	as	Caucasian	and	1	as	Hispanic.		
	
b.	HAI	Titer	
In	fall	2015,	all	pre-	and	post-vaccination	serum	HAIs	for	the	15	subjects	selected	for	the	
sample	population	were	completed	successfully	and	HAI	titers	were	determined	(Table	3).		
Overall,	there	was	a	trend	for	both	pre-	and	post-vaccinated	HAI	titers	of	exercisers	to	
be	higher	than	non-exercisers,	although	this	was	determined	to	not	be	statistically	significant	
(Fig.	3).	Observing	the	4	sub-groups,	healthy	weight	exercisers,	overweight	exercisers,	healthy	
weight	non-exercisers,	and	overweight	non-exercisers,	all	experienced	an	increase	in	antibody	
response	from	pre-	to	post-vaccination	(Fig.	4).	Differences	in	pre-	and	post-vaccinated	HAI	
Table	3.	Demographic	and	HAI	titer	data	from	the	2013-2014	sample	study	population.	
BMI Age Race Sex Exercise Pre- Post- Fold	Change
Healthy	Weight	Non-exercisers	
1505 24 83.5 Caucasian	 Female 1&2 10 20 2
1644 19.4 44.4 African	AmericanMale 1 20 160 8
1945 23.3 61.5 Caucasian	 Male 1&2 80 80 1
Overweight	Non-exercisers
1850 26.2 61.2 Caucasian	 Female 1&2 10 20 2
1893 27 32.1 Caucasian	 Male 1&2 40 80 2
1748 27.3 64.9 Caucasian	 Female 1&2 20 20 1
1979 28.2 39 Asian Male 1&2 20 20 1
Healthy	Weight	exercisers	
1667 22.7 34.1 Caucasian	 Female 6&7 40 160 4
1963 23.6 23 Hispanic	 Female 6&7 80 320 4
1955 17.6 18.6 Caucasian Male 7 320 640 2
1936 19.8 67.4 Caucasian Male 7 10 40 4
Overweight	Exercisers
1679 25.4 55.4 Caucasian Male 6&7 80 160 2
1886 25.7 38.8 Caucasian Male 6&7 40 320 8
1698 27.9 53.4 Caucasian Female 6&7 20 40 2
1938 26 58.3 Caucasian Male 7 20 40 2
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titers	between	healthy	weight	exercisers	and	non-exercisers	were	found	to	be	statistically	
insignificant	(pre:	P=	0.416,	post	P=0.253).	Pre/post	vaccination	comparisons	of	overweight	
exercisers	and	non-exercisers	were	also	found	to	be	statistically	insignificant	(pre:	P	=0.301,	
post:	P	=0.174).	The	HAI	titer	fold	change	was	used	as	the	main	determinant	for	the	role	of	
exercise	in	antibody	response	to	influenza	vaccination	(Fig.	5).	One-way	ANOVA	analysis	
determined	no	statistically	significant	difference	of	titer	fold	change	between	the	four	sub-
groups	(P=0.541).		
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Figure	3.	Pre-	and	post-vaccination	antibody	titer	response	in	exercisers	and	
non-exercisers:	(a)	pre-vaccination	P=0.251,	(b)	post-vaccination	P=0.073.	
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Figure	4.		Pre-	and	post-vaccination	antibody	titer	levels	of	body	weight	and	
exercise	status	subgroups.		No	significant	difference	in	titer	level	between	
healthy	weight	non-exercisers	and	exercisers	in	both	pre-	and	post-vaccination	
(pre:	P=0.416,	post:	P=0.253).	No	significant	difference	in	titer	level	between	
overweight	non-exercisers	and	exercisers	in	both	pre-	and	post-vaccination	(pre:	
P=0.301,	post:	P=0.174).	
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Figure	5.	H1N1	Titer	Fold	Change	for	body	weight	and	exercise	subgroups.	No	
significant	difference	(P=0.541).			
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IV.	Discussion		
a. Findings		
Influenza	is	considered	to	be	one	of	the	most	serious	communicable	diseases	due	to	its	
contagious	nature	and	potential	for	severe	health	complications.	The	2009	influenza	season	
was	classified	as	the	first	pandemic	in	over	four	decades.	In	the	United	States	alone,	there	were	
an	estimated	60.8	million	cases	reported	for	influenza	A	(H1N1)	infection,	12,469	of	which	
resulted	in	death10.	Global	mortality	estimates	from	the	2009	H1N1	influenza	season	are	
between	151,700	and	575,400	people2.	Seasonal	vaccination	has	been	found	to	be	the	most	
effective	protective	measure	against	acquiring	influenza.	Prior	studies	within	the	Beck	lab	have	
shown	that	obesity	can	impair	the	antibody	response	to	influenza	vaccination9.	Given	this	
study’s	finding	and	the	fact	that	obesity	is	now	considered	an	epidemic,	overall	decreased	
influenza	protection	by	vaccination	becomes	a	serious	public	health	concern.		
Nutrition,	among	other	factors,	plays	a	role	in	both	obesity	and	the	immune	response.		
A	multitude	of	other	factors	such	as	genetic	susceptibility,	age,	certain	exposures,	and	various	
lifestyle	habits	can	also	play	a	role	in	the	functionality	of	an	individual’s	immune	system.		
Exercise	is	often	suggested	as	one	of	the	most	important	health	behaviors	for	improving	health.	
Although	it	is	known	that	exercise	has	health	benefits	that	extend	beyond	body	weight	control,	
few	studies	have	looked	into	the	effects	on	antibody	response	to	vaccination,	specifically	
influenza	vaccination.	The	purpose	of	this	study	was	to	investigate	whether	or	not	exercise	can	
serve	a	mediating	role	in	antibody	immune	response	to	influenza	vaccination	in	healthy	weight	
and	overweight	individuals.		
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Based	on	evidence	from	limited	prior	studies	investigating	the	association	between	
exercise	and	antibody	response,	it	was	hypothesized	that	exercise	in	both	healthy	weight	and	
overweight	individuals	would	result	in	an	increased	influenza-specific	antibody	response	
following	flu	vaccination.	This	study	predicted	that	healthy	weight	and	overweight	exercisers	
would	have	a	larger	increase	in	the	titer	from	pre	to	post	vaccine	than	non-exercising	healthy	
weight	and	overweight	individuals.		However,	data	from	this	study	did	not	support	the	
hypothesis.	Although	no	significant	associations	were	found,	the	data	suggests	possible	trends	
that	warrant	further	investigation.		
Strictly	comparing	exercise	status	only,	Fig.	3	suggested	a	trend	toward	higher	antibody	
titers	in	exercisers	both	pre-	and	post-vaccination	as	compared	to	non-exercisers.	Similarly,	as	
shown	in	Fig.	4,	pre-	and	post-vaccination	antibody	titers	are	higher	in	healthy	weight	exercisers	
and	overweight	exercisers	than	their	non-exercising	counterpart	subgroups.	Titer	fold	changes	
from	Fig.	5	seem	to	be	comparable	between	healthy	weight	non-exercisers,	healthy	weight	
exercisers,	and	overweight	exercisers.	Overweight	non-exercisers	differ	by	almost	an	entire	2-
fold	difference.		
It	is	important	that	these	trends	be	viewed	with	caution	due	to	the	small	sample	size	
and	therefore	strong	effect	of	outliers	on	individual	subgroup	data.	Outliers	seemed	to	play	a	
noteworthy	role	in	this	study.	The	healthy	weight	exerciser	subject	with	a	pre-vaccination	titer	
of	320	and	post-vaccination	of	640	classified	as	an	outlier	for	the	subgroup	and	the	sample	
population	as	a	whole.	This	needs	to	be	taken	into	consideration	when	considering	the	trends.			
Comparing	this	data	to	the	Kohut	and	Woods	prior	studies	previously	discussed,	
although	our	data	is	statistically	insignificant,	the	trends	follow	the	similar	findings.		Both	of	
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these	studies	found	a	greater	titer	response	in	exercising	individuals	versus	non-exercisers.		The	
most	significant	differences	between	our	study	and	the	published	literature	was	age	of	
subjects,	sample	population	size,	and	previous	exercise	status.	Both	these	case-control	studies	
focused	more	on	the	older	population,	as	this	population	is	found	to	have	reduced	immune	
responses	and	the	greatest	influenza	illness	and	death	rates.	The	Kohut	study	included	27	
adults	greater	than	64	years	old	with	no	meaningful	exercise	history.	Similarly,	the	Woods	study	
included	144	adults	aged	60	to	83	who	had	all	been	considered	sedentary	prior	to	the	study	
intervention.	Our	study	included	15	participants	ages	18.6-83.5	whose	exercise	status	was	at	
the	discretion	of	the	subject	due	to	the	nature	of	the	study	design	and	therefore	exercise	
duration	could	not	be	accurately	accounted	for.			
The	earlier	studies	included	several	risk	factors:	older	age	and	prior	sedentary	lifestyle.		
As	such,	it	would	be	expected	for	a	significant,	more	dramatic	changes	in	overall	health	and	
immune	response	to	vaccine	after	exposing	these	individuals	to	exercise	and	vaccination	
compared	to	our	subjects	who	were	at	younger	ages	and	possible	prior	exercisers.	In	addition,	
both	the	Kohut	and	Woods	studies	had	a	larger	sample	population	size,	allowing	the	studies	
more	statistical	power	and	significance.			
b.	Study	Limitations		
There	were	several	limitations	within	this	study.		As	there	were	only	15	subjects	within	
the	sample	population,	sample	size	was	the	most	significant	limiting	factor	for	the	study.		It	was	
difficult	to	find	any	statistically	significant	differences	between	groups	when	each	group	only	
contained	3	or	4	subjects.		As	previously	discussed,	the	small	sample	size	increases	distortion	of	
statistic	estimates	due	to	the	strong	influence	of	the	outliers.		The	age	range	for	this	sample	
	 21	
population	was	quite	large	(64.9	years,	18.6-83.5	y.o.)	and	as	such	age	could	have	played	a	
strong	confounding	role.		
The	small	sample	size	was	due	to	the	limited	number	of	subjects	in	the	entire	study	
population	reporting	substantial	exercise.	Although	the	original	study	did	not	primarily	target	
exercise,	exercise	data	was	collected	from	a	self-reported	questionnaire	completed	at	the	time	
of	pre-vaccination	blood	draw.	Due	to	the	self-reported	nature	of	the	questionnaire,	it	was	
found	that	a	fair	percentage	of	the	questionnaires	were	not	filled	out	accurately	or	completely.	
These	subjects	were	therefore	not	able	to	be	considered	as	part	of	the	sample	population	and	
limited	subject	selection	for	the	sample	population.	Inaccurate	reporting	and	possible	recall	
bias	from	the	self-reported	questionnaire	could	have	resulted	in	an	underestimation	or	
overestimation	of	the	true	exercise	estimations	and	as	such	distorted	exercise	subgroup	
classification.		
Body	Mass	Index	(BMI)	was	used	as	the	measure	to	classify	subjects	as	healthy	weight	or	
overweight.	BMI	is	simply	the	ratio	of	weight	to	height	and	therefore	only	an	indirect	measure	
of	body	fat	as	it	does	not	take	into	account	body	mass	type,	specifically	fat	versus	muscle.		
Individuals	with	high	muscle	mass	can	often	be	classified	as	overweight	or	obese	when	their	
body	fat	is	much	less	than	that	for	defined	obesity.	Because	we	used	BMI	as	our	measure,	
subjects	with	high	muscle	mass	could	have	been	wrongly	classified	into	the	overweight	
category	when	actually	their	body	fat	percentage	is	below	the	overweight	cut	point.		This	could	
have	resulted	in	misclassification,	especially	among	the	exercisers,	and	therefore	skewed	the	
data.		
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c.	Future	Studies		
	 As	important	trends	associated	exercise	with	enhanced	influenza	vaccination	antibody	
response	were	seen	in	this	study,	future	studies	are	recommended.	Unfortunately,	due	to	small	
sample	size,	the	power	of	this	study	was	low	and	as	such	statistical	significance	was	not	found.	
In	order	to	increase	the	power	of	this	study,	the	subject	sample	size	must	be	larger.		Expanding	
the	sample	size	will	better	allow	control	for	potential	confounders	such	as	age	and	gender	as	
well	as	limit	the	effect	of	outliers.		
As	exercise	data	was	scarce,	increasing	exercise	data	collection	and	accuracy	would	
contribute	to	a	much	larger	subject	pool.	Exercise	data	accuracy	can	be	achieved	through	
stricter	exercise	control	such	as	a	monitored	implemented	regimen.		Regimens	could	be	
implemented	using	group	fitness	classes,	personal	trainers,	or	even	step	monitors.	In	addition,	
exercise	training	types	should	be	investigated	to	determine	the	benefits	of	cardio	versus	
strength	training.		
To	best	determine	body	weight	categories	in	future	studies,	BMI	should	not	be	used.		
There	are	several	other	body	fat	measurement	techniques	that	can	better	differentiate	
between	muscle	mass	and	fat	mass	and	therefore	provide	a	truer	classification	of	weight	status.	
If	cost	is	an	issue,	a	relatively	cheap	device	such	as	calipers	can	be	used	to	measure	skin	fold	
thickness	to	determine	relative	fatness.		More	advanced	methods	that	measure	actual	body	
composition	include	bioelectrical	impedance,	air	displacement	plethysmography,	hydrostatic	
weighing,	and	dual-energy	X-ray	absorptiometry.		It	is	also	important	to	take	into	account	the	
locations	of	extra	body	fat,	as	abdominal	fat	in	particular	has	been	linked	to	higher	cases	of	
metabolic	and	cardiovascular	diseases	and	morbidity1.				
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